To receive daily emails from Breaking Christian News to your inbox CLICK HERE
Israeli Scientists Hopeful for New Treatment to Fight Secondary Cancer"Our advance is very exciting, as today there are no drugs in production that prevent metastasis, (or) in other words exist especially to stop cancer from spreading. Most drugs are focused on shrinking tumors once they develop. We are taking a preventive approach, which could save many from a second illness and save many lives." – Dr. Hava Gil-Henn
The spread of cancer cells from a primary tumor to body tissues or organs is the major cause of death for cancer patients, and is responsible for 90 percent of breast cancer deaths. The scientists' efforts focused on breast cancer in mice, but they believe the success of their peer-reviewed study, published in the journal, Oncogene, would apply to other kinds of cancers as well. Typically, cancer treatment has focused on reducing the primary tumor in a patient, but there is no treatment currently that prevents metastatic cancer, the kind that breaks down cells and travels through the bloodstream to other body parts. The molecular blockers produced by the Tel Aviv researchers did that successfully in the mice. Cells from primary tumors often develop structures like feet, called invadopodia, which enable the cell to break away from the tumor and batter down the walls of other cells, setting up a malignancy elsewhere in the body. Co-author of the Bar Ilan study, Professor Jordan Chill, told The Times of Israel, "We believe that this can prevent the activation of the invadopodia and therefore inhibit metastasis. I expect that it could be used in addition to chemotherapy or other treatments that kill cancer cells." The Times of Israel quoted the other co-author of the study, Dr. Hava Gil-Henn, who said, "Our advance is very exciting, as today there are no drugs in production that prevent metastasis, (or) in other words exist especially to stop cancer from spreading." Gil-Henn added, "Most drugs are focused on shrinking tumors once they develop. We are taking a preventive approach, which could save many from a second illness and save many lives." Subscribe for free to Breaking Christian News here
To receive daily emails from Breaking Christian News to your inbox CLICK HERE
Other Recent Articles from Breaking Christian News 'It's a Fairness Issue': Speaker McCarthy Promises to Protect Women's Sports from Transgender Threat Bill Protecting Minors from Gender Transition Surgeries and Drugs Advances in Tennessee Legislature House Ousts Antisemitic Ilhan Omar from Foreign Affairs Committee in Party Line Vote Prayer Alert: Republican New Jersey Councilwoman Fatally Shot Outside Her Home DoD 'Continuing to Monitor' Chinese Spy Balloon Floating Over US; No Order to Shoot It Down What Do Conservative US Evangelicals and Right-Wing Israeli Religious Jews Have in Common? 'The Holy Spirit Did the Work': How the Owner of Two Strip Clubs Came to Jesus and Shut Them Down Arizona Sheriff Testifies of 'Modern Day Slavery' at Border, Says Biden Turned on 'Welcome Sign' Speaker McCarthy, Many Other Leaders Gather for Prayer and Repentance Prior to Prayer Breakfast 70th National Prayer Breakfast Aims to Return to Roots, Build Unity Report: Nikki Haley Set to Launch Presidential Bid on February 15 'Most Extreme' In Nation: Minnesota Legalizes Abortion to Birth With No Restrictions Biden Administration May Declare 'Public Health Emergency' over Abortion Access Search the Articles Archives |
All articles on this site and emails from BCN are copyrighted property of Breaking Christian News. Permission is given to link to, or share a BCN story if proper attribution is given to both the original writer and summarizer of the story. Breaking Christian News 2005-2019. All Rights Reserved.
Breaking Christian News is a division of Elijah List Publications, Inc. All Rights Reserved
Disclaimer: Articles and links, as well as the source articles linked to; do not necessarily reflect the opinion of Breaking Christian News.
Home | Store | Subscribe | Facebook | Article Archive |